Cassyni Biopharma

Cassyni biopharma email format

Verified email-pattern data for Cassyni Biopharma is currently limited. You can still use the company insights and contact sections below.
-Cassyni was successfully acquired by Antharis Therapeutics Inc, in July 2022. We developed monoclonal antibodies to fight human infectious and inflammatory diseases, and now continue these efforts under Antharis Therapeutics Inc.
Looking for a particular Cassyni Biopharma employee's phone or email?

Cassyni Biopharma Questions

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant